Actively Recruiting
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Led by UroGen Pharma Ltd. · Updated on 2025-02-28
400
Participants Needed
22
Research Sites
215 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.
CONDITIONS
Official Title
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults >18 years old and capable of giving informed consent.
- Diagnosis of UTUC.
- Receipt of at least 1 dose of JELMYTO after FDA approval (15 Apr 2020).
You will not qualify if you...
- Incapable of giving informed consent (e.g., incarcerated individuals, individuals with dementia).
- Receipt of 1 or more doses of JELMYTO before FDA approval (on or before 15 Apr 2020).
- Pregnancy or lactation.
- Unable to comply with protocol requirements (for prospective data capture).
- Any medical or mental condition(s) that makes participation inadvisable in the opinion of the Investigator (for prospective data capture).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 22 locations
1
Providence St. Johns Health Center
Santa Monica, California, United States, 90404
Actively Recruiting
2
University of Florida
Gainesville, Florida, United States, 32610
Actively Recruiting
3
Mount Sinai Medical Center of Florida, Inc.
Miami, Florida, United States, 33140
Actively Recruiting
4
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, Florida, United States, 33612
Actively Recruiting
5
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
6
Indiana University
Indianapolis, Indiana, United States, 46202
Actively Recruiting
7
The State University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
8
Chesapeake Urology
Baltimore, Maryland, United States, 21204
Actively Recruiting
9
Johns Hopkins Medical Center
Baltimore, Maryland, United States, 21287
Actively Recruiting
10
Mass General Hospital (MGH)
Boston, Massachusetts, United States, 02114
Actively Recruiting
11
The Brigham and Womens Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
12
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
13
University of Missouri
Columbia, Missouri, United States, 65211
Actively Recruiting
14
Rutgers
New Brunswick, New Jersey, United States, 08903
Actively Recruiting
15
The Feinstein Institutes for Medical Research
Lake Success, New York, United States, 11042
Actively Recruiting
16
NYU Grossman School of Medicine
New York, New York, United States, 10016
Actively Recruiting
17
SUNY Upstate
Syracuse, New York, United States, 13210
Actively Recruiting
18
The University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
19
Ohio State University
Columbus, Ohio, United States, 43202
Actively Recruiting
20
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
21
UT Southwestern Medical Center
Dallas, Texas, United States, 75390
Actively Recruiting
22
The University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
M
Michael Louie, MD, MPH, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here